Purpose 1 Protocol Amendment 3.0 training
| Name | UVRI-IAVI HIV VACCINE PROGRAM |
|---|
| Activity Title | Purpose 1 Protocol Amendment 3.0 training |
|---|
| Details | Purpose 1 study is A Phase 3, Double-Blinded, Multicenter, Randomized Study to Evaluate Safety and Efficacy of Twice Yearly Long-Acting Subcutaneous Lenacapavir, and Daily Oral Emtricitabine/Tenofovir Alafenamide for Pre-Exposure Prophylaxis in Adolescent Girls and Young Women at Risk of HIV Infection. A new protocol amendment 3.0 was recently published. Prior to implementation, staff have to be trained on it. |
|---|
| Competence | Public Health |
|---|
| Start Date | 17-05-2024 |
|---|
| End Date | 17-05-2024 |
|---|
| Event Time | 09:00 AM |
|---|
| Location | UVRI-IAVI |
|---|
| Cost (UGX) | 0 |
|---|
| CPD Points | 5 |
|---|